Timely intervention in HMG-CoA Lyase deficiency: The role of newborn screening, metabolic management, and genomic sequencingHMG-CoA裂解酶缺乏症的及时干预:新生儿筛查、代谢管理和基因组测序的作用MOLECULAR GENETICS AND METABOLISM REPORTSIF1.92025-11-010OAAI
Early presentation of Morquio B syndrome identified via skeletal et biochemical findingsMOLECULAR GENETICS AND METABOLISMIF3.52024-04-010PRE
Critical sample collection delayed? Urine organic acid analysis can still save the day!MOLECULAR GENETICS AND METABOLISMIF3.52024-04-010PRE
Tandem mass spectrometry analysis of dried urine spots for newborn screening of mucopolysaccharidosesMOLECULAR GENETICS AND METABOLISMIF3.52023-02-010PRE
Quantitation of a Urinary Profile of Biomarkers in Gaucher Disease Type 1 Patients Using Tandem Mass SpectrometryDIAGNOSTICSIF3.32022-06-086OAAI
Metabolomic Study Using Time-of-Flight Mass Spectrometry Reveals Novel Urinary Biomarkers for Gaucher Disease Type 1JOURNAL OF PROTEOME RESEARCHIF3.62022-03-295PRE
Plasma biomarker profile quantification by tandem mass spectrometry for early detection of Gaucher diseaseMOLECULAR GENETICS AND METABOLISMIF3.52022-02-010PRE
Metabolomic study for the identification and characterization of novel Gaucher disease biomarkersMOLECULAR GENETICS AND METABOLISMIF3.52021-02-010PREAI
The importance of mass spectrometry-based untargeted metabolomic approaches for biomarker discovery in lysosomal diseasesMOLECULAR GENETICS AND METABOLISMIF3.52021-02-010PREAI
Neonatal Mass Urine Screening Approach for Early Detection of Mucopolysaccharidoses by UPLC-MS/MSDIAGNOSTICSIF3.32019-11-1812OAAI
Separation and Analysis of Lactosylceramide, Galabiosylceramide, and Globotriaosylceramide by LC-MS/MS in Urine of Fabry Disease PatientsANALYTICAL CHEMISTRYIF6.72017-11-2734PREAI